ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,955, issued on Sept. 22, was assigned to Cambridge Enterprise Ltd. (Cambridge, Great Britain).
"Treatment or prevention of ischaemic stroke reperfusion injury" was invented by Michael Patrick Murphy (Cambridge, Great Britain) and Thomas Krieg (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to salts and compositions for use in the treatment of ischaemic stroke reperfusion (IR) injury. In particular, the present invention relates to a salt of formula (I) for use in treating or preventing ischaemic stroke reperfusion injury, wherein X, Y, n, m, Z, A and B are as defined herein."
The patent was fi...